Asciminib in HER2+ Breast Cancer Brain Metastases
Asciminib in HER2+ Breast Cancer Brain Metastases
Recruiting · NCT07136428 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Asciminib in HER2+ Breast Cancer Brain Metastases | HER2+ Metastatic Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2026-07-22 | NCT07136428 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
| Novartis | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University | Durham | United States | 160 |